TY - JOUR
T1 - Cough in asthma is due to eosinophilic airway inflammation
T2 - A Pro/Con debate
AU - Niimi, Akio
AU - Brightling, Christopher E.
AU - Dicpinigaitis, Peter V.
N1 - Funding Information:
Dr. Niimi has received funding in the form of a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture (23591117) of the Japanese government. He has received consultancy fees and research funding from AstraZeneca, Astellas, GlaxoSmithKline, Kyorin, MSD, Boehringer-Ingelheim, and Novartis. Dr. Brightling has received funding in the form of a Wellcome Senior Clinical Fellowship and has received consultancy fees and research funding from AstraZeneca, MedImmune, GlaxoSmithKline, Chiesi, Roche, and Novartis. Dr. Dicpinigaitis has received consultancy fees from Pfizer, Novartis, and GlaxoSmithKline and serves on the speakers’ bureau of Boehringer-Ingelheim.
PY - 2014/2
Y1 - 2014/2
N2 - Multiple prospective studies have demonstrated that asthma is among the most common etiologies of chronic cough, along with upper-airway cough syndrome (formerly known as postnasal drip syndrome) and gastroesophageal reflux disease. More recently, the entity of nonasthmatic eosinophilic bronchitis has been appreciated as a significant cause of chronic cough worldwide. Chronic cough associated with both of these conditions typically responds well to therapy with systemic or inhaled corticosteroids, thus leading to a general assumption that the suppression of eosinophilic airway inflammation explains the improvement in cough. However, some recent studies challenge a causal relationship between eosinophilic airway inflammation and cough in asthmatics. The 4th American Cough Conference, held in New York in June 2013, provided an ideal forum for discussion and debate of this issue between two internationally recognized experts in the field of asthma and chronic cough.
AB - Multiple prospective studies have demonstrated that asthma is among the most common etiologies of chronic cough, along with upper-airway cough syndrome (formerly known as postnasal drip syndrome) and gastroesophageal reflux disease. More recently, the entity of nonasthmatic eosinophilic bronchitis has been appreciated as a significant cause of chronic cough worldwide. Chronic cough associated with both of these conditions typically responds well to therapy with systemic or inhaled corticosteroids, thus leading to a general assumption that the suppression of eosinophilic airway inflammation explains the improvement in cough. However, some recent studies challenge a causal relationship between eosinophilic airway inflammation and cough in asthmatics. The 4th American Cough Conference, held in New York in June 2013, provided an ideal forum for discussion and debate of this issue between two internationally recognized experts in the field of asthma and chronic cough.
KW - Asthma
KW - Cough
KW - Eosinophil
KW - Inflammation
UR - http://www.scopus.com/inward/record.url?scp=84894106125&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894106125&partnerID=8YFLogxK
U2 - 10.1007/s00408-013-9543-8
DO - 10.1007/s00408-013-9543-8
M3 - Article
C2 - 24337175
AN - SCOPUS:84894106125
VL - 192
SP - 33
EP - 38
JO - Pneumonologie. Pneumonology
JF - Pneumonologie. Pneumonology
SN - 0341-2040
IS - 1
ER -